SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-211881
Filing Date
2022-08-04
Accepted
2022-08-04 08:28:55
Documents
54
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d321742d10q.htm   iXBRL 10-Q 1782662
2 EX-31.1 d321742dex311.htm EX-31.1 6933
3 EX-31.2 d321742dex312.htm EX-31.2 7132
4 EX-32.1 d321742dex321.htm EX-32.1 5633
  Complete submission text file 0001193125-22-211881.txt   5459751

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mgta-20220630.xsd EX-101.SCH 32314
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20220630_cal.xml EX-101.CAL 40181
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20220630_def.xml EX-101.DEF 223289
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20220630_lab.xml EX-101.LAB 304910
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20220630_pre.xml EX-101.PRE 265254
48 EXTRACTED XBRL INSTANCE DOCUMENT d321742d10q_htm.xml XML 687036
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 221134864
SIC: 2834 Pharmaceutical Preparations